Stock LSB LAKESHORE BIOPHARMA CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Consensus LakeShore Biopharma Co., Ltd

Equities

LSB

KYG9845F1090

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-06-21 EDT 		5-day change 1st Jan Change
0.6 USD +2.56% Intraday chart for LakeShore Biopharma Co., Ltd -14.00% +17.42%
06-10 Lakeshore Biopharma Co., Ltd Announces Executive Changes CI
05-28 YS Biopharma Co., Ltd. will Change its Ticker to LSB from YS CI

Evolution of the average Target Price on LakeShore Biopharma Co., Ltd

Price target over the last 5 years

History of analyst recommendation changes

0f841b0a1ef598b3c9615ac9cac52.vFss266Xc3KqIZ2Pv5Tn9NRvOwva977HGjlYoeiwEDw.3wpcjcf8OxqbVPTY2cWyrrVaQ1yWtoiwKmof7ZnaYFHoEGC8x_UZQfVLpQ~36b888d54627d3ea62d5b010cef75455

Analyst Recommendations on LakeShore Biopharma Co., Ltd

Noble Capital Initiates YS Biopharma With Outperform Rating, $5.25 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.357 CNY
Average target price
29.98 CNY
Spread / Average Target
+588.20%
High Price Target
37.51 CNY
Spread / Highest target
+760.94%
Low Price Target
22.46 CNY
Spread / Lowest Target
+415.45%

Consensus detail

Consensus revision (last 18 months)

Analysts covering LakeShore Biopharma Co., Ltd

Noble Capital

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. LSB Stock
  4. Consensus LakeShore Biopharma Co., Ltd